
Journal of Organic Chemistry p. 8723 - 8731 (2020)
Update date:2022-08-03
Topics:
Li, Junlan
Liu, Lihua
Zheng, Kaiting
Zheng, Chenggong
Xiao, Hua
Fan, Shilu
The incorporation of a perfluoroalkyl group (RF) into drug candidates has become an increasingly important strategy in drug molecule design. In this study, the silver-mediated perfluoroalkylation reaction based on the addition-elimination process of terminal alkynes which was initiated by a perfluoroalkyl radical to form a C(sp)-RF bond has been developed. The reaction proceeds under mild conditions using readily available, low-cost perfluoroalkyl iodides as the sources of the RF group. This method allows access to a variety of perfluoroalkylated alkynes.
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Contact:86-512-69362780,69362785
Address:No.69 Weixin Road,Weiting Town,Suzhou Industrial Park
website:http://www.shengmaochem.com
Contact:86-27-82853423, 82819281
Address:Rm 202, A Unit Huaqiao Building No. 2, Lihuangpi Road, Wuhan, China
Xinchang Yueding Chemical Co., Ltd.
Contact:86-571-56926323
Address:NO.90 BEIMENCHENGWAI CHENGGUAN TOWN XINCHANG
Contact:+86 18616952870
Address:Area
Doi:10.1139/v74-205
(1974)Doi:10.1021/jo00938a010
(1974)Doi:10.1021/ja00339a017
(1983)Doi:10.1002/ejic.200390019
(2003)Doi:10.1021/jo00256a014
(1988)Doi:10.1021/ja00008a058
(1991)